Ardmore Shipping Exercises Newbuilding Options

HAMILTON, Bermuda, Aug. 27, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced it has exercised the options for a further two 40,500 dwt Handysize product/chemical tankers to be built at Wuhu Shipyard. This expands the original order to six vessels in total on similar terms, and the Company has no further options outstanding.

PRNewsWire • Aug 27, 2026

ASC 842 Is About To Drop A Bomb On AI Hype

AI hyperscalers like Microsoft, Meta, Amazon, and Alphabet face a looming liability surge as ASC 842 lease accounting rules hit. ASC 842 will force recognition of long-term lease obligations on balance sheets, materially increasing reported leverage and altering financial optics.

Seeking Alpha • Aug 26, 2026

Graham Value All-Stars (GVAS) Emit 12 Bright August Buys

The August GVAS list highlights 42 large-cap value stocks, emphasizing high-yield 'dividend dogs' with strong relative value metrics. Analyst targets project 30%–55% net gains for the top ten GVAS stocks by August 2027, with an average estimated return of 40.61% and below-market volatility. Twelve of twenty-one 'safer' GVAS stocks are currently fairly priced and ideal for purchase, based on positive free cash flow yields and dividend safety.

Seeking Alpha • Aug 14, 2026

Ardmore Shipping Q2 Earnings Call Highlights

Ardmore Shipping NYSE: ASC reported second-quarter adjusted earnings of $48.3 million, or $1.18 per share, as product tanker market conditions remained strong. The company declared a quarterly dividend of $0.79 per share, consistent with its policy of distributing two-thirds of adjusted earnings.

MarketBeat • Jul 29, 2026

Ardmore Shipping Corporation (ASC) Q2 2026 Earnings Call Transcript

Ardmore Shipping Corporation (ASC) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 29, 2026

Ardmore Shipping Corporation Announces Financial Results For The Three and Six Months Ended June 30, 2026

HAMILTON, Bermuda, July 29, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore", the "Company" or "we") today announced results for the three and six months ended June 30, 2026. Highlights and Recent Activity Reported net income attributable to common stockholders of $60.5 million for the three months ended June 30, 2026, or $1.48 earnings per basic and diluted share, compared to net income attributable to common stockholders of $9.0 million, or $0.22 earnings per basic and diluted share for the three months ended June 30, 2025.

PRNewsWire • Jul 29, 2026

Ardmore Shipping Announces Second Quarter 2026 Conference Call and Webcast

HAMILTON, Bermuda, July 22, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that the Company plans to announce its second quarter earnings before the market opens on Wednesday, July 29, 2026 and will host a conference call later in the day at 10:00 a.m. Eastern Time.

PRNewsWire • Jul 22, 2026

Ardmore Shipping: The War Is The Wrong Reason To Own It - Buy

Ardmore Shipping offers a compelling payout story, with Q2 spot MRs fixed at $52,100/day—nearly 5x cash breakeven—and a doubled dividend policy. ASC's Q2 earnings are largely locked in, supporting an estimated $0.83/share dividend and a projected $2.89/share full-year EPS at current run-rates. The stock is rated Buy with a $17 target, underpinned by a 12.4% yield, disciplined capital allocation, and a strong balance sheet with low leverage.

Seeking Alpha • Jul 16, 2026

July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys

July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks meeting this ideal condition.

Seeking Alpha • Jul 11, 2026

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

CHICAGO & MILPITAS, Calif.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome engineering, today announced a strategic collaboration to help unlock the next generation of regenerative medicine. The collaboration will focus on evaluating ASC's iPSC and hypoimmune cell lines using Syntax Bio's proprietary Cellgorithm™ platform to advanc.

Business Wire • Jun 23, 2026